NOVAVAX INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$10.08
-3.72%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-4.9%
3 months
+36.0%
6 months
+25.4%
1 year
+19.6%
Year to date
+50.0%
52-week range
$6.22 – $12.82
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.66B
P/E
-6.7
P/B
-8.7
P/S
4
Revenue
$413.8M
Net income
-$247.73M
Diluted EPS
-1.52
Gross margin
78.60%
Net margin
-59.90%
Return on equity
159.90%
Total debt
$297.32M
Cash
$191.46M
Free cash flow
-$43.03M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $56.7M | -$53.39M | 74.90% | -94.20% | -$73.4M |
| Mar 31, 2026 | $139.51M | -$9.49M | 78.00% | -6.80% | -$33.69M |
| Dec 31, 2025 | $147.14M | $17.53M | 85.00% | 11.90% | -$41.72M |
| Sep 30, 2025 | $70.45M | -$202.38M | 69.50% | -287.30% | $105.79M |
| Jun 30, 2025 | $239.24M | $106.51M | 93.60% | 44.50% | -$127.99M |
| Mar 31, 2025 | $666.66M | $518.65M | 97.90% | 77.80% | -$187.1M |
| Dec 31, 2024 | $88.31M | -$81.03M | 58.50% | -91.80% | -$175.42M |
| Sep 30, 2024 | $84.51M | -$121.3M | 28.30% | -143.50% | -$146.83M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent NVAX news
All market newsNo ticker-linked stories are in the current archive.